BIOMAT Database Logo BIOMAT Database Logo

The thermal stability of a stabilized 17D yellow fever virus vaccine. 1977

C Burfoot, and P A Young, and N B Finter

UI MeSH Term Description Entries
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005612 Freeze Drying Method of tissue preparation in which the tissue specimen is frozen and then dehydrated at low temperature in a high vacuum. This method is also used for dehydrating pharmaceutical and food products. Lyophilization,Drying, Freeze,Dryings, Freeze,Freeze Dryings,Lyophilizations
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral
D014776 Virus Cultivation Process of growing viruses in live animals, plants, or cultured cells. Viral Cultivation,Cultivation, Viral,Cultivation, Virus,Cultivations, Viral,Cultivations, Virus,Viral Cultivations,Virus Cultivations
D015005 Yellow fever virus The type species of the FLAVIVIRUS genus. Principal vector transmission to humans is by AEDES spp. mosquitoes.

Related Publications

C Burfoot, and P A Young, and N B Finter
17D Yellow Fever Virus Vaccine.
December 2013, The American journal of tropical medicine and hygiene,
C Burfoot, and P A Young, and N B Finter
[Thermal stability of lyophilized 17D yellow fever virus vaccine. I. Trial of protective substances].
October 1984, Journal of biological standardization,
C Burfoot, and P A Young, and N B Finter
Stability of 17D yellow fever virus vaccine using different stabilizers.
December 1998, Biologicals : journal of the International Association of Biological Standardization,
C Burfoot, and P A Young, and N B Finter
[Stability of a new thermostable 17D yellow fever vaccine].
January 1988, Journal of biological standardization,
C Burfoot, and P A Young, and N B Finter
Stability-related studies on 17D yellow fever vaccine.
January 2000, Microbes and infection,
C Burfoot, and P A Young, and N B Finter
A clinical study of stabilized 17D strain live attenuated yellow fever vaccine.
October 1981, Journal of biological standardization,
C Burfoot, and P A Young, and N B Finter
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.
February 2006, Virology,
C Burfoot, and P A Young, and N B Finter
The preparation of 17D virus yellow fever vaccine in mouse brain.
June 1955, Annals of tropical medicine and parasitology,
C Burfoot, and P A Young, and N B Finter
[Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983].
January 1985, Bulletin de la Societe de pathologie exotique et de ses filiales,
C Burfoot, and P A Young, and N B Finter
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses.
December 2021, Vaccines,
Copied contents to your clipboard!